DIFFERENTIATION OF BORRELIACIDAL ACTIVITY CAUSED BY IMMUNE SERUM OR ANTIMICROBIAL AGENTS BY FLOW-CYTOMETRY

被引:6
作者
LIU, YF
LIM, LCL
SCHELL, K
LOVRICH, SD
CALLISTER, SM
SCHELL, RF
机构
[1] UNIV WISCONSIN,WISCONSIN STATE LAB HYG,MADISON,WI 53706
[2] UNIV WISCONSIN,DEPT BACTERIOL,MADISON,WI 53706
[3] UNIV WISCONSIN,DEPT MED MICROBIOL & IMMUNOL,MADISON,WI 53706
[4] UNIV WISCONSIN,CTR COMPREHENS CANC,FLOW CYTOMETRY UNIT,MADISON,WI 53706
[5] GUNDERSON MED FDN,LA CROSSE,WI 54601
关键词
D O I
10.1128/CDLI.1.2.145-149.1994
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We demonstrated that borreliacidal activity caused by immune serum and complement can easily be differentiated by flow cytometry from killing activity caused by antimicrobial agents that are commonly used for the treatment of Lyme disease. Assay suspensions containing normal or immune serum were incubated with Borrelia burgdorferi in the presence or absence of ceftriaxone, doxycycline, penicillin, and phosphomycin for 2, 8, 16 and 24 h. Samples containing killing activity were identified by using flow cytometry and acridine orange. In 30 min, the effects of immune serum and complement were easily distinguished from the killing of spirochetes by antimicrobial agents by adding fluorescein isothiocyanate-conjugated goat anti-hamster immunoglobulin. This simple procedure greatly enhanced the usefulness of the borreliacidal assay by eliminating a major source of false-positive reactions.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 19 条
[1]   INVITRO SUSCEPTIBILITIES OF BORRELIA-BURGDORFERI TO 5 ORAL CEPHALOSPORINS AND CEFTRIAXONE [J].
AGGER, WA ;
CALLISTER, SM ;
JOBE, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1788-1790
[2]   PERFORMANCE OF 45 LABORATORIES PARTICIPATING IN A PROFICIENCY TESTING PROGRAM FOR LYME-DISEASE SEROLOGY [J].
BAKKEN, LL ;
CASE, KL ;
CALLISTER, SM ;
BOURDEAU, NJ ;
SCHELL, RF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (07) :891-895
[3]   LYME-DISEASE ASSAY WHICH DETECTS KILLED BORRELIA-BURGDORFERI [J].
CALLISTER, SM ;
SCHELL, RF ;
LOVRICH, SD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (09) :1773-1776
[4]   CHARACTERIZATION OF THE BORRELIACIDAL ANTIBODY-RESPONSE TO BORRELIA-BURGDORFERI IN HUMANS - A SERODIAGNOSTIC TEST [J].
CALLISTER, SM ;
SCHELL, RF ;
CASE, KL ;
LOVRICH, SD ;
DAY, SP .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :158-164
[5]   EFFECTS OF BOVINE SERUM-ALBUMIN ON THE ABILITY OF BARBOUR-STOENNER-KELLY MEDIUM TO DETECT BORRELIA-BURGDORFERI [J].
CALLISTER, SM ;
CASE, KL ;
AGGER, WA ;
SCHELL, RF ;
JOHNSON, RC ;
ELLINGSON, JLE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (02) :363-365
[6]   LONG-TERM PROTECTION OF MICE FROM LYME-DISEASE BY VACCINATION WITH OSPA [J].
FIKRIG, E ;
BARTHOLD, SW ;
KANTOR, FS ;
FLAVELL, RA .
INFECTION AND IMMUNITY, 1992, 60 (03) :773-777
[7]   AN INTERLABORATORY STUDY OF ANTIBODY TO BORRELIA-BURGDORFERI [J].
HEDBERG, CW ;
OSTERHOLM, MT ;
MACDONALD, KL ;
WHITE, KE .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (06) :1325-1327
[8]  
Heinisch O., 1960, PRINCIPLES PROCEDURE, P481, DOI 10.1002/bimj.19620040313
[9]   INTERLABORATORY AND INTRALABORATORY COMPARISONS OF INDIRECT IMMUNOFLUORESCENCE ASSAYS FOR SERODIAGNOSIS OF LYME-DISEASE [J].
LANE, RS ;
LENNETTE, ET ;
MADIGAN, JE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (08) :1774-1779
[10]   IN-VITRO SUSCEPTIBILITY OF BORRELIA-BURGDORFERI TO 11 ANTIMICROBIAL AGENTS [J].
LEVIN, JM ;
NELSON, JA ;
SEGRETI, J ;
HARRISON, B ;
BENSON, CA ;
STRLE, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (07) :1444-1446